CAD 0.57
(7.55%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 878.87 Million USD | -7.55% |
2022 | 950.61 Million USD | 29.32% |
2021 | 735.07 Million USD | 21.72% |
2020 | 603.88 Million CAD | 31.06% |
2019 | 460.76 Million CAD | 417.84% |
2018 | 88.97 Million CAD | 28.84% |
2017 | 69.06 Million CAD | 1685.83% |
2016 | 3.86 Million CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 887.1 Million USD | 0.94% |
2024 Q2 | 660.24 Million USD | -25.57% |
2023 FY | 878.87 Million USD | -7.55% |
2023 Q4 | 878.87 Million USD | -11.52% |
2023 Q3 | 993.26 Million USD | 4.0% |
2023 Q2 | 955.05 Million USD | 0.59% |
2023 Q1 | 949.47 Million USD | -0.12% |
2022 Q3 | 996.85 Million CAD | -23.38% |
2022 Q2 | 1.3 Billion CAD | 0.51% |
2022 Q1 | 1.29 Billion CAD | 76.11% |
2022 Q4 | 950.61 Million CAD | -4.64% |
2021 Q4 | 735.06 Million CAD | -13.57% |
2021 Q3 | 850.51 Million CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aurora Cannabis Inc. | 838.67 Million CAD | -4.793% |
Avicanna Inc. | 21.97 Million CAD | -3900.12% |
Avant Brands Inc. | 82.55 Million CAD | -964.627% |
Cardiol Therapeutics Inc. | 36.7 Million CAD | -2294.71% |
Crescita Therapeutics Inc. | 24.59 Million CAD | -3472.935% |
Knight Therapeutics Inc. | 945.49 Million CAD | 7.046% |
MediPharm Labs Corp. | 63.93 Million CAD | -1274.588% |
OrganiGram Holdings Inc. | 298.45 Million CAD | -194.473% |
Canopy Growth Corporation | 1.3 Billion CAD | 32.412% |
Willow Biosciences Inc. | 6.67 Million CAD | -13070.547% |
Auxly Cannabis Group Inc. | 261.9 Million CAD | -235.57% |